Exploring advances in bioconjugation: nanozymes, tissue tropism, and the future of responsive systems

“ADCs represent a success story for bioconjugation, however, they are also a cautionary tale.”Lauren Coyle (Commissioning Editor, Bioconjugation Insights) speaks to Vincent Rotello (Distinguished Professor of Chemistry, University of Massachusetts Amherst) about the advantages and limitations of different nanomaterial platforms, and emerging strategies such as tissue tropism and responsive nanozymes that could advance targeted therapeutic and diagnostic delivery.